Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-02-25 @ 11:04 PM
Study NCT ID:
NCT03912402
Status:
UNKNOWN
Last Update Posted:
2019-05-09
First Post:
2019-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Sponsor:
Biocad
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-07-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-10
First Submit QC Date:
None
Study First Post Date:
2019-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-08
Last Update Post Date:
2019-05-09
Last Update Post Date Type:
ACTUAL